A detailed history of Puzo Michael J transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Puzo Michael J holds 5,300 shares of BMY stock, worth $281,907. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,300
Previous 6,100 13.11%
Holding current value
$281,907
Previous $330,000 33.33%
% of portfolio
0.06%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $32,200 - $42,392
-800 Reduced 13.11%
5,300 $220,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $26,389 - $29,920
-550 Reduced 8.27%
6,100 $330,000
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $72,720 - $86,775
-1,500 Reduced 18.4%
6,650 $341,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $5,789 - $6,473
-100 Reduced 1.21%
8,150 $473,000
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $12,742 - $14,147
-200 Reduced 2.37%
8,250 $527,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $40,083 - $45,463
-610 Reduced 6.73%
8,450 $585,000
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $146 - $86,368
-1,124 Reduced 11.04%
9,060 $644,000
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $32,178 - $37,512
-600 Reduced 5.56%
10,184 $634,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $33,200 - $37,622
-575 Reduced 5.06%
10,784 $668,000
Q3 2020

Oct 28, 2020

SELL
$57.43 - $63.64 $1,435 - $1,591
-25 Reduced 0.22%
11,359 $686,000
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $34,043 - $39,799
-621 Reduced 5.17%
11,384 $670,000
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $28,953 - $42,076
624 Added 5.48%
12,005 $669,000
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $40,401 - $52,699
821 Added 7.77%
11,381 $732,000
Q3 2019

Nov 06, 2019

SELL
$42.77 - $50.71 $47,047 - $55,781
-1,100 Reduced 9.43%
10,560 $534,000
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $8,924 - $9,868
-200 Reduced 1.69%
11,660 $528,000
Q1 2019

May 01, 2019

SELL
$45.12 - $53.8 $90,240 - $107,600
-2,000 Reduced 14.43%
11,860 $566,000
Q4 2018

Jan 24, 2019

SELL
$48.76 - $63.23 $53,636 - $69,553
-1,100 Reduced 7.35%
13,860 $721,000
Q2 2018

Jul 30, 2018

SELL
$50.53 - $62.98 $82,869 - $103,287
-1,640 Reduced 9.88%
14,960 $828,000
Q1 2018

Apr 24, 2018

SELL
$59.92 - $68.98 $89,880 - $103,470
-1,500 Reduced 8.29%
16,600 $1.05 Million
Q4 2017

Feb 02, 2018

BUY
$59.94 - $65.35 $413,586 - $450,914
6,900 Added 61.61%
18,100 $1.11 Million
Q3 2017

Oct 26, 2017

BUY
$55.23 - $63.74 $618,576 - $713,888
11,200
11,200 $714,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Puzo Michael J Portfolio

Follow Puzo Michael J and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.